{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:47:41Z","timestamp":1791985661466,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009776","name":"Gavleborg Region","doi-asserted-by":"publisher","award":["974248"],"award-info":[{"award-number":["974248"]}],"id":[{"id":"10.13039\/501100009776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ygyno.2025.04.592","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T23:26:16Z","timestamp":1746746776000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Splenectomy as an indicator for ovarian cancer spread and complete cytoreduction"],"prefix":"10.1016","volume":"197","author":[{"given":"Evelina","family":"Karlsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Vorobii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilvars","family":"Silins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Sundstr\u00f6m Poromaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"St\u00e5lberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Lomnytska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2025.04.592_bb0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO\u2013ESMO\u2013ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease","volume":"35","author":"Ledermann","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0015","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0020","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0025","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the arbeitsgemeinschaft gynaekologische onkologie studiengruppe ovarialkarzin","volume":"115","author":"Du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2025.04.592_bb0030","article-title":"Splenectomy and surgical cytoreduction in epithelial ovarian cancer: a review","author":"Hanprasertpong","year":"2011","journal-title":"Eur. J. Cancer Care (Engl.)"},{"key":"10.1016\/j.ygyno.2025.04.592_bb0035","doi-asserted-by":"crossref","DOI":"10.2147\/CMAR.S172687","article-title":"Splenectomy during cytoreductive surgery in epithelial ovarian cancer","author":"Sun","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/aogs.14286","article-title":"Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population-based cohort study","volume":"101","author":"Said","year":"2022","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2022.08.023","article-title":"Splenectomy at the time of primary or interval cytoreductive surgery for epithelial ovarian carcinoma: a review of outcomes","author":"Rush","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2010.05.031","article-title":"The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas","author":"Chi","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0055","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/ijgc-2022-003928","article-title":"Splenectomy in epithelial ovarian cancer surgery","volume":"33","author":"El Hajj","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2025.04.592_bb0060","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/cancers16040790","article-title":"Splenectomy as part of maximal-effort cytoreductive surgery in advanced epithelial ovarian cancer","volume":"16","author":"Pergialiotis","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2025.04.592_bb0065","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","article-title":"The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0070","first-page":"1","article-title":"Splenectomy as a part of cytoreductive surgery in ovarian cancer: systematic review and meta-analysis","author":"Wang","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2025.04.592_bb0075","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00404-019-05300-y","article-title":"Metastasis patterns of the spleen and association with survival outcomes in advanced ovarian\u2013tubal\u2013peritoneal epithelial cancer","volume":"300","author":"Durmu\u015f","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ygyno.2006.03.028","article-title":"Splenectomy as part of cytoreductive surgery in ovarian cancer","volume":"102","author":"Magtibay","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0085","first-page":"5649","article-title":"Hematogenous splenic metastases as an independent negative prognosis factor at the moment of primary cytoreduction in advanced stage epithelial ovarian cancer - a single center experience","volume":"35","author":"Bacalbasa","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0090","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0095","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijscr.2020.05.086","article-title":"Splenic metastases-hematogenous disease or invasive peritoneal implants? Case reports of two patients","volume":"72","author":"Sugarbaker","year":"2020","journal-title":"Int. J. Surg. Case Rep."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0115","doi-asserted-by":"crossref","first-page":"676.e1","DOI":"10.1016\/j.ajog.2007.10.495","article-title":"Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer","volume":"197","author":"Aletti","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0120","article-title":"Successful management of microscopic residual disease in large bowel cancer","volume":"43 Suppl","author":"Sugarbaker","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0130","first-page":"557","article-title":"Metastases observed autopsy in 70 women with ovarian cancer: relationship to treatment","volume":"2","author":"Kataoka","year":"1995","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0135","article-title":"Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery","volume":"2022","author":"Bryant","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0140","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1245\/s10434-020-08649-6","article-title":"The peritoneal cancer index is a strong predictor of incomplete cytoreductive surgery in ovarian cancer","volume":"28","author":"J\u00f3nsd\u00f3ttir","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0145","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.ejso.2021.05.019","article-title":"Peritoneal cancer index predicts severe complications after ovarian cancer surgery","volume":"47","author":"Lomnytska","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/ejso.2002.1380","article-title":"Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer","volume":"29","author":"Tentes","year":"2003","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0155","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejca.2012.07.023","article-title":"Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials","volume":"49","author":"Mahner","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2025.04.592_bb0160","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.2147\/CMAR.S313013","article-title":"Impact of the time interval between primary debulking surgery and start of adjuvant chemotherapy in advanced epithelial ovarian cancer","volume":"13","author":"Lin","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0165","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ygyno.2018.07.004","article-title":"Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer","volume":"150","author":"Timmermans","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0170","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejso.2020.07.025","article-title":"Time-interval to adjuvant chemotherapy and postoperative management after upper abdominal surgical procedures in advanced ovarian cancer","volume":"47","author":"Joneborg","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4682-3-23","article-title":"The paradoxical effects of splenectomy on tumor growth","volume":"3","author":"Prehn","year":"2006","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0180","first-page":"385","article-title":"Effect of splenectomy on antitumor immune system in mice","volume":"29","author":"Higashijima","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0203820","article-title":"Adverse prognostic impact of splenectomy on survival in gastric carcinoma patients: regression and propensity score matching analysis of 1074 patients","volume":"13","author":"Jeong","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2025.04.592_bb0190","doi-asserted-by":"crossref","first-page":"807","DOI":"10.5603\/GP.a2023.0028","article-title":"The impact of splenectomy and diaphragmatic surgery on perioperative morbidity and overall survival of ovarian cancer patients","volume":"94","author":"Skowyra","year":"2023","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.ygyno.2025.04.592_bb0195","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1245\/s10434-011-1661-z","article-title":"Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer","volume":"18","author":"McCann","year":"2011","journal-title":"Ann. Surg. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825008182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825008182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:06:33Z","timestamp":1791983193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825008182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":39,"alternative-id":["S0090825825008182"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.04.592","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splenectomy as an indicator for ovarian cancer spread and complete cytoreduction","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.04.592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}